⚠ Evidence note: Human outcome data on longevity interventions is limited; most claims rest on surrogate markers or animal models. Nothing here is medical advice.
Rentosertib
Current understanding
To be populated as evidence accumulates.
Evidence log
- 2026-09-07 — Insilico’s IPF candidate rentosertib shows anti-aging promise: FirstWord Pharma trade-press item frames Insilico Medicine’s AI-discovered IPF candidate rentosertib as having anti-aging promise; headline-only coverage, no primary longevity data disclosed. [expert-opinion] (novelty: 3)
Open questions
Related
Contributing findings
Insilico's IPF candidate rentosertib shows anti-aging promise
07-sep-2026
novelty 3
per-area 3
strengthens